- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-6-6-6-mer
- Ligands
- 6 x SPH: SPHINGOSINE(Non-covalent)
- 6 x K: POTASSIUM ION(Non-covalent)
K.2: 5 residues within 4Å:- Chain A: Q.189
- Chain C: V.20, S.21
- Chain F: K.7, P.8
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:P.8
K.11: 3 residues within 4Å:- Chain D: Q.189
- Chain F: V.20, S.21
No protein-ligand interaction detected (PLIP)K.20: 3 residues within 4Å:- Chain G: Q.189
- Chain I: V.20, S.21
No protein-ligand interaction detected (PLIP)K.29: 5 residues within 4Å:- Chain I: K.7, P.8
- Chain J: Q.189
- Chain L: V.20, S.21
1 PLIP interactions:1 interactions with chain I- Metal complexes: I:P.8
K.38: 5 residues within 4Å:- Chain M: Q.189
- Chain O: V.20, S.21
- Chain R: K.7, P.8
1 PLIP interactions:1 interactions with chain R- Metal complexes: R:P.8
K.47: 3 residues within 4Å:- Chain P: Q.189
- Chain R: V.20, S.21
No protein-ligand interaction detected (PLIP)- 42 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 2 residues within 4Å:- Chain A: R.236
- Chain D: R.250
Ligand excluded by PLIPCL.4: 4 residues within 4Å:- Chain A: K.256, H.257, V.258
- Chain B: Q.44
Ligand excluded by PLIPCL.5: 4 residues within 4Å:- Chain B: H.231, P.232, Y.233
- Chain C: M.66
Ligand excluded by PLIPCL.6: 2 residues within 4Å:- Chain B: K.138, S.139
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain B: T.137
- Chain O: T.79
Ligand excluded by PLIPCL.8: 7 residues within 4Å:- Chain B: N.15, K.34
- Chain C: G.27
- Chain D: Q.76, N.82
- Chain E: R.43, Q.44
Ligand excluded by PLIPCL.9: 6 residues within 4Å:- Chain C: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.12: 1 residues within 4Å:- Chain D: R.236
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain D: K.256, H.257, V.258
- Chain E: Q.44
Ligand excluded by PLIPCL.14: 4 residues within 4Å:- Chain E: H.231, P.232, Y.233
- Chain F: M.66
Ligand excluded by PLIPCL.15: 2 residues within 4Å:- Chain E: K.138, S.139
Ligand excluded by PLIPCL.16: 1 residues within 4Å:- Chain E: T.137
Ligand excluded by PLIPCL.17: 3 residues within 4Å:- Chain E: N.15, K.34
- Chain F: G.27
Ligand excluded by PLIPCL.18: 6 residues within 4Å:- Chain F: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.21: 1 residues within 4Å:- Chain G: R.236
Ligand excluded by PLIPCL.22: 4 residues within 4Å:- Chain G: K.256, H.257, V.258
- Chain H: Q.44
Ligand excluded by PLIPCL.23: 4 residues within 4Å:- Chain H: H.231, P.232, Y.233
- Chain I: M.66
Ligand excluded by PLIPCL.24: 2 residues within 4Å:- Chain H: K.138, S.139
Ligand excluded by PLIPCL.25: 1 residues within 4Å:- Chain H: T.137
Ligand excluded by PLIPCL.26: 3 residues within 4Å:- Chain H: N.15, K.34
- Chain I: G.27
Ligand excluded by PLIPCL.27: 6 residues within 4Å:- Chain I: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain G: R.250
- Chain J: R.236
Ligand excluded by PLIPCL.31: 4 residues within 4Å:- Chain J: K.256, H.257, V.258
- Chain K: Q.44
Ligand excluded by PLIPCL.32: 4 residues within 4Å:- Chain K: H.231, P.232, Y.233
- Chain L: M.66
Ligand excluded by PLIPCL.33: 2 residues within 4Å:- Chain K: K.138, S.139
Ligand excluded by PLIPCL.34: 2 residues within 4Å:- Chain C: T.79
- Chain K: T.137
Ligand excluded by PLIPCL.35: 7 residues within 4Å:- Chain G: Q.76, N.82
- Chain H: R.43, Q.44
- Chain K: N.15, K.34
- Chain L: G.27
Ligand excluded by PLIPCL.36: 6 residues within 4Å:- Chain L: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain M: R.236
- Chain P: R.250
Ligand excluded by PLIPCL.40: 4 residues within 4Å:- Chain M: K.256, H.257, V.258
- Chain N: Q.44
Ligand excluded by PLIPCL.41: 4 residues within 4Å:- Chain N: H.231, P.232, Y.233
- Chain O: M.66
Ligand excluded by PLIPCL.42: 2 residues within 4Å:- Chain N: K.138, S.139
Ligand excluded by PLIPCL.43: 2 residues within 4Å:- Chain L: T.79
- Chain N: T.137
Ligand excluded by PLIPCL.44: 7 residues within 4Å:- Chain N: N.15, K.34
- Chain O: G.27
- Chain P: Q.76, N.82
- Chain Q: R.43, Q.44
Ligand excluded by PLIPCL.45: 6 residues within 4Å:- Chain O: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.48: 1 residues within 4Å:- Chain P: R.236
Ligand excluded by PLIPCL.49: 4 residues within 4Å:- Chain P: K.256, H.257, V.258
- Chain Q: Q.44
Ligand excluded by PLIPCL.50: 4 residues within 4Å:- Chain Q: H.231, P.232, Y.233
- Chain R: M.66
Ligand excluded by PLIPCL.51: 2 residues within 4Å:- Chain Q: K.138, S.139
Ligand excluded by PLIPCL.52: 1 residues within 4Å:- Chain Q: T.137
Ligand excluded by PLIPCL.53: 3 residues within 4Å:- Chain Q: N.15, K.34
- Chain R: G.27
Ligand excluded by PLIPCL.54: 6 residues within 4Å:- Chain R: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ren, J. et al., Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity. J.Virol. (2015)
- Release Date
- 2015-08-26
- Peptides
- VP1: ADGJMP
VP0: BEHKNQ
VP3: CFILOR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AM
AP
AB
BE
BH
BK
BN
BQ
BC
CF
CI
CL
CO
CR
C
SMTL ID : 5c9a.3 (3 other biounits)
Crystal structure of empty coxsackievirus A16 particle
VP1
Toggle Identical (ADGJMP)VP0
Toggle Identical (BEHKNQ)VP3
Toggle Identical (CFILOR)Related Entries With Identical Sequence
4jgy.1 | 4jgy.2 | 4jgy.3 | 4jgy.4 | 4jgy.5 | 4jgz.1 | 4jgz.2 | 4jgz.3 | 4jgz.4 | 4jgz.5 | 5abj.1 | 5abj.2 | 5abj.3 | 5abj.4 | 5c4w.1 | 5c4w.2 | 5c4w.3 | 5c4w.4 | 5c8c.1 | 5c8c.2 | 5c8c.3 | 5c8c.4 | 5c9a.1 | 5c9a.2 | 5c9a.4 | 5tsk.1 | 5tsk.2 | 5tsk.3 | 5tsk.4 | 5tsk.5 more...less...5tsk.6 | 5tsl.1 | 5tsl.2 | 5tsl.3 | 5tsl.4 | 5tsl.5 | 5tsl.6 | 6lha.1 | 6lha.2 | 6lha.3 | 6lha.4 | 6lhb.1 | 6lhb.2 | 6lhb.3 | 6lhb.4 | 6lhc.1 | 6lhc.2 | 6lhc.3 | 6lhc.4 | 6lhk.1 | 6lhk.2 | 6lhk.3 | 6lhk.4 | 6lhl.1 | 6lhl.2 | 6lhl.3 | 6lhl.4 | 6lho.1 | 6lho.2 | 6lho.3 | 6lho.4 | 6lhp.1 | 6lhp.2 | 6lhp.3 | 6lhp.4 | 6lhq.1 | 6lhq.2 | 6lhq.3 | 6lhq.4